Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD1 | P21728 | 1/20 | 0.35 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.31 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13626861 | 0.82 | — | — | |
| SCHEMBL13626875 | 0.80 | — | — | |
| SCHEMBL13626860 | 0.80 | DRD1 (0.36) | DRD1 | |
| SCHEMBL709313 | 0.79 | DRD1 (0.36) | DRD1GABBR2GABBR1 | |
| SCHEMBL13626849 | 0.76 | DRD1 (0.55) | DRD1 | |
| SCHEMBL13955180 | 0.76 | — | — | |
| SCHEMBL14141464 | 0.75 | — | — | |
| SCHEMBL13626889 | 0.75 | — | — | |
| SCHEMBL708320 | 0.75 | DRD1 (0.61) | DRD1GABBR2GABBR1 | |
| SCHEMBL13626881 | 0.73 | DRD1 (0.35) | DRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9795952-B2 | Bidentate ligands for hydroformylation of ethylene | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2017-10-24 | — | — | US | disclosed |
| US-9795952-B2 | Bidentate ligands for hydroformylation of ethylene | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2017-10-24 | — | — | US | disclosed |
| US-20150328628-A1 | Bidentate Ligands for Hydroformylation of Ethylene | THE DOW CHEMICAL COMPANY | 2015-11-19 | — | — | US | disclosed |
| US-7615645-B2 | Method for the continuous production of aldehydes | BASF AKTIENGESELLSCHAFT (DE) | 2009-11-10 | — | — | US | disclosed |
| US-7615645-B2 | Method for the continuous production of aldehydes | BASF AKTIENGESELLSCHAFT (DE) | 2009-11-10 | — | — | US | disclosed |
| US-20070083066-A1 | Method for the production of 1,7-octadiene and use thereof | BASF AKTIENGESELLSCHAFT (DE) | 2007-04-12 | — | — | US | disclosed |
| US-20070083066-A1 | Method for the production of 1,7-octadiene and use thereof | BASF AKTIENGESELLSCHAFT (DE) | 2007-04-12 | — | — | US | disclosed |
| US-7173138-B2 | Ligands for pnicogen chelate complexes with a metal of subgroup VIII and use of the complexes as catalysts for hydroformylation, carbonylation, hydrocyanation or hydrogenation | BASF AKTIENGESELLSCHAFT (DE) | 2007-02-06 | — | — | US | disclosed |
| US-7173138-B2 | Ligands for pnicogen chelate complexes with a metal of subgroup VIII and use of the complexes as catalysts for hydroformylation, carbonylation, hydrocyanation or hydrogenation | BASF AKTIENGESELLSCHAFT (DE) | 2007-02-06 | — | — | US | disclosed |
| US-20070004939-A1 | Method for the continuous production of aldehydes | VOLLAND MARTIN | 2007-01-04 | — | — | US | disclosed |
| US-20070004939-A1 | Method for the continuous production of aldehydes | VOLLAND MARTIN | 2007-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070004939-A1 | Method for the continuous production of aldehydes | HRH4, HRH2, HRH3 | DRD1 1338/4885GABBR2 799/4885GABBR1 905/4885 |
| US-20070083066-A1 | Method for the production of 1,7-octadiene and use thereof | CYP51A1, MSMO1, HSD17B7 | DRD1 92/4885GABBR2 2412/4885GABBR1 2192/4885 |
| US-20150328628-A1 | Bidentate Ligands for Hydroformylation of Ethylene | HRH4, HRH3, H1-4 | DRD1 1860/4885GABBR2 1219/4885GABBR1 1464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.